Cancer-associated missense mutations of caspase-8 activate nuclear factor-κB signaling

Cancer Science

Volumn 104, Issue 8, 2013, Pages 1002-1008

  Ando, Mizuo ^a   Kawazu, Masahito ^a   Ueno, Toshihide ^b   Fukumura, Kazutaka ^a   Yamato, Azusa ^b   Soda, Manabu ^b   Yamashita, Yoshihiro ^b   Choi, Young L ^a   Yamasoba, Tatsuya ^a   Mano, Hiroyuki ^a,b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CASPASE 8; COMPLEMENTARY DNA; GLYCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MUTANT PROTEIN; PROCASPASE 8;

AMINO ACID SUBSTITUTION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CODON; CONTROLLED STUDY; DNA PURIFICATION; DNA SEQUENCE; EMBRYO; EPITHELIUM TUMOR; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE IDENTIFICATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MALIGNANT TRANSFORMATION; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REPORTER GENE; SIGNAL TRANSDUCTION; TUMOR GENE; WILD TYPE;

EID: 84881094776     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12191     Document Type: Article

References (33)

1. Mao L, Hong WK, Papadimitrakopoulou VA. Focus on head and neck cancer. Cancer Cell 2004; 5: 311-6.
2. Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med 2008; 359: 1143-54.
3. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet 2008; 371: 1695-709.
4. Mardis ER. A decade's perspective on DNA sequencing technology. Nature 2011; 470: 198-203.
5. Ueno T, Yamashita Y, Soda M et al. High-throughput resequencing of target-captured cDNA in cancer cells. Cancer Sci 2012; 103: 131-5.
6. Onishi M, Kinoshita S, Morikawa Y et al. Applications of retrovirus-mediated expression cloning. Exp Hematol 1996; 24: 324-9.
7. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009; 10: R25.
8. Hu Q, Milfay D, Williams LT. Binding of NCK to SOS and activation of ras-dependent gene expression. Mol Cell Biol 1995; 15: 1169-74.
9. Takeshita T, Arita T, Higuchi M et al. STAM, signal transducing adaptor molecule, is associated with Janus kinase and involved in signaling for cell growth and c-myc induction. Immunity 1997; 6: 449-57.
10. El-Deiry WS, Tokino T, Velculescu VE et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-25.
11. Kurooka H, Kuroda K, Honjo T. Roles of the ankyrin repeats and C-terminal region of the mouse notch1 intracellular region. Nucleic Acids Res 1998; 26: 5448-55.
12. Hill CS, Wynne J, Treisman R. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 1995; 81: 1159-70.
13. Muzio M, Chinnaiyan AM, Kischkel FC et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996; 85: 817-27.
14. Chaudhary PM, Eby MT, Jasmin A, Kumar A, Liu L, Hood L. Activation of the NF-kappaB pathway by caspase 8 and its homologs. Oncogene 2000; 19: 4451-60.
15. Hu WH, Johnson H, Shu HB. Activation of NF-kappaB by FADD, Casper, and caspase-8. J Biol Chem 2000; 275: 10838-44.
16. Soung YH, Lee JW, Kim SY et al. Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas. Oncogene 2005; 24: 141-7.
17. Mandruzzato S, Brasseur F, Andry G, Boon T, van der Bruggen P. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J Exp Med 1997; 186: 785-93.
18. Kim HS, Lee JW, Soung YH et al. Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 2003; 125: 708-15.
19. Soung YH, Lee JW, Kim SY et al. CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res 2005; 65: 815-21.
20. Eberstadt M, Huang B, Chen Z et al. NMR structure and mutagenesis of the FADD (Mort1) death-effector domain. Nature 1998; 392: 941-5.
21. Tibbetts MD, Zheng L, Lenardo MJ. The death effector domain protein family: regulators of cellular homeostasis. Nat Immunol 2003; 4: 404-9.
22. Yu JW, Shi Y. FLIP and the death effector domain family. Oncogene 2008; 27: 6216-27.
23. Budd RC, Yeh WC, Tschopp J. cFLIP regulation of lymphocyte activation and development. Nat Rev Immunol 2006; 6: 196-204.
24. Kischkel FC, Lawrence DA, Tinel A et al. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem 2001; 276: 46639-46.
25. Wang J, Chun HJ, Wong W, Spencer DM, Lenardo MJ. Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci USA 2001; 98: 13884-8.
26. Sprick MR, Rieser E, Stahl H, Grosse-Wilde A, Weigand MA, Walczak H. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8. EMBO J 2002; 21: 4520-30.
27. Shikama Y, Yamada M, Miyashita T. Caspase-8 and caspase-10 activate NF-kappaB through RIP, NIK and IKKalpha kinases. Eur J Immunol 2003; 33: 1998-2006.
28. Pop C, Fitzgerald P, Green DR, Salvesen GS. Role of proteolysis in caspase-8 activation and stabilization. Biochemistry 2007; 46: 4398-407.
29. Krammer PH. CD95's deadly mission in the immune system. Nature 2000; 407: 789-95.
30. Heyninck K, Beyaert R. Crosstalk between NF-kappaB-activating and apoptosis-inducing proteins of the TNF-receptor complex. Mol Cell Biol Res Commun 2001; 4: 259-65.
31. Varfolomeev E, Maecker H, Sharp D et al. Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand. J Biol Chem 2005; 280: 40599-608.
32. Golks A, Brenner D, Krammer PH, Lavrik IN. The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation. J Exp Med 2006; 203: 1295-305.
33. Stransky N, Egloff AM, Tward AD et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011; 333: 1157-60.